CC(Oc1ccccc1)C(=O)NC1C(=O)N2C(C(=O)[O-])C(C)(C)S[C@@H]12.[K+]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?